Abstract
Introduction

Arterial calcification is often seen in studies using various imaging techniques. Although radiological techniques to visualize calcification are emerging, observing calcification is usually a coincidence on images performed for indications other than detecting calcified arteries. These calcifications are not as innocent as doctors tend to believe. They usually harbour an increased vascular risk
. [2] . Calcification of the vascular wall has been shown to predict increased cardiovascular risk, independent of the classical cardiovascular risk factors [3] [4] [5] [6] .
Deposits of calcium in the vascular wall can be detected with Xray. When vascular structures on X-ray images of the chest, the abdomen or extremities have similar density compared to bone, calcification is diagnosed. These images, however, are not valid for quantification of calcium. Using computed tomography (CT), the density of pixels is expressed as Hounsfield units and calcium is usually suspected when a pixel exceeds 130 Hounsfield units. At least in the coronary arteries, this technique is currently the only validated technique for quantification of vascular calcification
Vascular calcification consists of calcium salt precipitates, mostly in apatite form, similar to the hydroxyapatite found in bone. Several risk factors which are associated with the presence or progression of vascular calcification have been identified [3, 7] . In the past vascular calcification was seen as an inert end-point of atherosclerosis, however, recently it has become clear that it is a actively regulated process already occurring in the early stages of atherosclerotic lesions [8] [9] [10] .
Many new pathways regulating calcification are being discovered. Recent [3] . Most of the risk factors associated with calcification of the aortic arch are also well known cardiovascular risk factors (Table 1) . Despite this similarity, aortic arch calcification itself is an independent predictor of cardiovascular risk [3] . Recent research showed changes in the mechanical properties of the atherosclerotic lesion and increased inflammation in response to calcification, which may increase the risk of plaque rupture [3, 18, 19] [75] . In dialysis patients, serum fetuin-A negatively correlates with CAC [76] . It has been shown that low fetuin-A levels were associated with higher all-cause and cardiovascular mortality [77] [78] [79] . [31, 39, 80, 81] [53, [86] [87] [88] [84, 89, 90] . In addition, associations may differ between groups using calcium-containing or calcium-free phosphate binding therapy [91] . It has been suggested that vascular calcification under uremic conditions may act as a natural 'stent' by 'stabilizing' plaques [92, 93] . Arterial disease would then lead to less acute ischemic events, but more chronic ischemia and fibrosis through progressive luminal obliteration [92] . Arterial media calcification is mostly localized in muscletype conduit arteries such as femoral and tibial arteries. These lesions in their most pure form do not obstruct the arterial lumen. This form of calcification has been associated with increased arterial stiffness and mortality [94, 95] . 
Fetuin-A
Fetuin-A is a serum glycoprotein produced in the liver and present in high serum concentrations (0.4-1.0 g/l) [71]. In end-stage renal disease patients the role of fetuin-A has been extensively studied. With a molecular weight of 56 kD it is non-dialysable. It acts as a negative acute phase protein and is a powerful calcification inhibitor [71-73]. Together with MGP, fetuin-A is able to make up a complex with calcium and phosphate thereby transporting and clearing the insoluble calcium-phosphate salt, and preventing its extra skeletal deposition [74]. In transgenic fetuin-A deficient mice (fetuin-A -/-mice), extra skeletal calcification, including soft tissue and peri-vertebral arterial calcification develop [72]. Large arteries are spared from calcifications, most likely because of up-regulation of other potent calcification inhibitors such as MGP and OPN
This effect was partially mediated by inflammation, according to its correlation with higher levels of C-reactive protein. If there is an imbalance between the calcification protective and calcification inducing factors, progressive vascular calcification can be the result. Figure 1 depicts the different proteins and their role in the calcification process. First the conventional vascular risk factors result in intimal damage and sub-intimal lipid deposition. Subsequently, the inflammatory response induced leads to increased BMP-2. If not balanced by active (carboxylated) MGP, multipotent mesenchymal vascular cells are stimulated to differentiation into 'osteoblast-like' cells. At this point the presence of sufficient active MGP is important both for blocking the action of BMP-2 and for binding directly to calcium crystals in the vascular matrix
. Although the role of PTH in bone formation is eminent, the importance of PTH for vascular calcification in dialysis patients is less clear. Some studies show an association between PTH levels and vascular calcification, whereas others do not
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